Profound Medical Corp.

NASDAQ: PROF · Real-Time Price · USD
4.33
-1.21 (-21.84%)
At close: Aug 15, 2025, 2:59 PM

Profound Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.62M 3.71M 2.83M 2.23M 1.91M 2.01M 1.73M 1.6M 1.86M 1.26M 2.04M 2.02M 1.36M 998K 2.54M 2.63M 711K
Cost of Revenue
768K 1.18M 1.03M 795K 641K 950K 668K 552K 647K 698K 945K 1.09M 928K 501K 1.55M 1.41M 459K
Gross Profit
1.85M 2.52M 1.79M 1.44M 1.27M 1.06M 1.06M 1.05M 1.21M 559K 1.09M 936K 436K 497K 987K 1.22M 252K
Operating Income
-11.17M -8.76M -9M 7.83M -7.48M -8.78M -6.56M 6.44M -6.84M -6.3M -8.23M -7.78M -7.29M -9.73M -7.61M -6.38M -6.57M
Interest Income
n/a 322.63K 221.77K 786.75K 850.96K 1.37M 1.01M 320.17K 157.01K 524.79K 248K 243K 78K 89K 22K 46K 48K
Pretax Income
-10.68M -5.57M -9.19M -6.9M -6.16M -9.14M -5.55M -7.32M -6.69M -9.32M -4.96M -5.91M -8.18M -10.19M -5.94M -6.99M -7.47M
Net Income
-10.72M -4.81M -9.37M -6.92M -6.2M -8.91M -5.56M -7.36M -6.74M -9.53M -5M -5.93M -8.21M -10.16M -6M -7.04M -7.5M
Selling & General & Admin
8.21M 6.6M 6.62M 5.08M 4.82M 5.87M 4.21M 4.33M 4.21M 3.77M 4.59M 5.03M 4.55M 5.53M 4.54M 4.18M 3.72M
Research & Development
4.81M 4.68M 4.17M 4.19M 3.93M 3.97M 3.42M 3.15M 3.84M 3.09M 4.73M 3.69M 3.18M 4.7M 4.05M 3.42M 3.1M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a -12.87M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
13.02M 11.28M 10.79M -6.39M 8.75M 9.84M 7.62M 7.49M 8.05M 6.86M 9.32M 8.71M 7.73M 10.22M 8.59M 7.6M 6.82M
Interest Expense
n/a 419.28K 199K -147.25K -471.04K 14.81K n/a 194.53K 192.01K 128.19K 14K 16K 16K 584.92K 22K 23K 22K
Selling & Marketing Expenses
n/a n/a 2.92M 2.97M 2.43M 2.92M 2.18M 2.25M 2.1M 1.67M 2.2M 2.39M 2.2M 2.3M 2.03M 1.73M 1.59M
Cost & Expenses
13.79M 12.46M 11.83M 10.07M 9.39M 10.79M 8.29M -4.83M 8.7M 7.55M 10.27M 9.8M 8.66M 10.73M 10.14M 9.01M 7.28M
Income Tax Expense
41K -238K 177K 20K 39K -229K 18K 35K 48K 206K 34K 16K 31K -31K 52K 57K 27K
Shares Outstanding (Basic)
30.04M 25.77M 24.64M 24.44M 23.84M 21.37M 21.28M 21.17M 20.92M 20.71M 20.82M 20.79M 20.78M 20.78M 20.41M 20.35M 20.28M
Shares Outstanding (Diluted)
30.04M 25.77M 24.64M 24.44M 23.84M 21.37M 21.4M 21.17M 20.92M 20.86M 20.86M 20.79M 20.78M 20.78M 20.41M 20.35M 20.28M
EPS (Basic)
-0.36 -0.2 -0.38 -0.28 -0.26 -0.42 -0.26 -0.35 -0.32 -0.46 -0.24 -0.29 -0.4 -0.49 -0.29 -0.35 -0.37
EPS (Diluted)
-0.36 -0.2 -0.38 -0.28 -0.26 -0.42 -0.26 -0.35 -0.32 -0.46 -0.24 -0.29 -0.4 -0.49 -0.29 -0.35 -0.37
EBITDA
-11M -8.68M -8.72M -7.55M -7.66M -7.79M -6.79M -6.16M -6.55M -8.31M -7.86M -6.9M -6.74M -9.7M -6.85M -6.49M -7.03M
EBIT
-11.17M -8.76M -9.26M -7.83M -7.48M -8.09M -6.56M -6.44M -6.84M -9.19M -8.23M -5.9M -8.17M -10.19M -5.92M -6.96M -7.45M
Depreciation & Amortization
163K 76K 268K 287K 411.32K 407.24K 384.94K 277K 382.77K 347.55K 495.03K 634.62K 606.71K 625.26K 613.66K 578.29K 538.15K